Universitätsklinikum Ulm

Hospital


Location: Ulm, Germany (DE) DE

ISNI: -

ROR: https://ror.org/05emabm63

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SLC20A1 Is Involved in Urinary Tract and Urorectal Development (2020) Rieke JM, Zhang R, Braun D, Yilmaz Ö, Japp AS, Lopes FM, Pleschka M, et al. Journal article Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells (2020) Bosso M, Prelli Bozzo C, Hotter D, Volcic M, Stürzel CM, Rammelt A, Ni Y, et al. Journal article Summer is getting active - the self-introduction of GeSRU (2020) Koenig J, Mattigk A, Beck A, Wundrack FM, Bellut L, Fassbach M Journal article, Editorial Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis (2020) Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, et al. Journal article Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (2020) Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, et al. Journal article Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning (2020) Wustrau K, Greil J, Sykora KW, Albert MH, Burkhardt B, Lang P, Meisel R, et al. Journal article Further Education and GeSRU. Activities during Covid Times (2020) Mattigk A, Beck A, Fassbach M, Wundrack FM, Koenig J, Bellut L Journal article, Editorial DETECT III und IV - Individualisierte CTC-basierte Therapie des HER2-negativen metastasierten Mammakarzinoms (2020) Friedl TWP, Schneeweiss A, Mueller , Riethdorf S, Pantel K, Taran FA, Polasik A, et al. Conference contribution DETECT V/CHEVENDO - duale HER2-zielgerichteten Therapie mit Trastuzumab und Pertuzumab plus Ribociclib in Kombination mit Chemotherapie oder endokriner Therapie bei Patientinnen mit HER2-positivem und hormonrezeptor-positivem metastasierten Mammakarzinom (2020) Friedl TWP, Polasik A, Tzschaschel M, Schochter F, De Gregorio A, Fasching P, Taran FA, et al. Conference contribution CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial (2020) Stockmann H, Keller T, Büttner S, Jörres A, Kindgen-Milles D, Kunz JV, Leebmann J, et al. Journal article